According to IRIN News, Mozambique has completed its first HIV vaccine trial and is set to embark on a second, a demonstration of the country’s increased HIV research capacity. This may just be the holly-grail Africa need; so help us God.. in this research.
This week, researchers at Mozambique’s Polana Cancio Centre for Research and Public Health completed a trial evaluating the safety of an HIV vaccine candidate. The study was conducted through the UK HIV Vaccine Consortium’s Tanzania and Mozambique HIV Vaccine Programme (TaMoVac). Preliminary results from the Phase I trial indicated the vaccine was safe, but researchers say it will be months before they know if the vaccine produced an immune response in participants. Click here to read more.
No comments:
Post a Comment